Mesothelioma is a complicated illness. Because the number of patients we see in a year is among the highest in the United States, our experts have a very high level of familiarity and expertise in diagnosing and treating pleural mesothelioma, peritoneal mesothelioma, and other forms of the disease.
The mesothelioma experts at Memorial Sloan Kettering Cancer Center (MSK) are recognized around the world for their leadership in evaluating and treating the disease. Your personal treatment team will include a wide range of specialists who will customize a plan of care that fits your unique needs.
Your team includes specialists in surgery, medical oncology, pathology, nursing, and social work. Having experts from all of these areas on your team ensures that your treatment plan takes care of all of your needs.
Select from the list below to learn more about our mesothelioma specialists, including their education, training, board certifications, current publications, and specific areas of clinical expertise.
Surgery (Pleural Mesothelioma)
Director, Quality and Outcomes, Thoracic Surgery Service, Director, Memorial Hospital Step Down Unit, Co-Director, Thoracic Liquid Biopsy Program
Director, Esophageal Surgery Program
Deputy Chief and Attending, Thoracic Service; Vice Chair for Translational Research, Department of Surgery; Co-Director, Mesothelioma Program; Head, Solid Tumors Cell Therapy, Cellular Therapeutics Center
Deputy Chief of Clinical Affairs, Thoracic Service
Vice Chair for Clinical Research, Department of Surgery; Miner Family Chair in Intrathoracic Cancers
Medical Oncology (Pleural Mesothelioma)
Radiation Oncology (Pleural Mesothelioma)
Director, Thoracic Radiation Oncology; Vice Chair of Clinical Operations, Department of Radiation Oncology
Director, Thoracic Radiation Oncology Research
Chief Medical Officer, New York Proton Center
Vice Chair, Graduate Medical Education Committee
Radiology (Pleural Mesothelioma)
Vice Chair for Education, Department of Radiology
Director of General Radiology
Pathology
Chief, Molecular Diagnostics Service; William J. Ruane Chair in Molecular Oncology
Director, Thoracic Pathology
Surgery (Peritoneal Mesothelioma)
Vice Chair for Quality and Safety, Department of Surgery
Medical Oncology (Peritoneal Mesothelioma)
Section Head, Colorectal Cancer; Co-Director, Center for Young Onset Colorectal and Gastrointestinal Cancers
Radiology (Peritoneal Mesothelioma)
Director of General Radiology
Radiation Oncology (Peritoneal Mesothelioma)
Vice Chair, Graduate Medical Education Committee
